What We Do       Leadership       Therapeutic Areas       Partnering       News       Contact

Management Team

Joel joined moksha8 in December 2014 as CEO. He has over 35 years of experience in the pharmaceutical industry, most of it has been spent in Latin America; working for leading pharmaceutical companies such as Sanofi and UCB. His most recent role, Joel was Interlatina regional manager for Sanofi, Latin America regional manager for UCB and CEO of Meizler UCB Brazil.

Joel brings extensive experience in leading highly successful teams, merging, acquiring, launching and marketing pharmaceutical products in Latin America, particularly in the CNS, Diabetes, Oncology and Respiratory therapeutic areas.

 

Joel Barlan

Chief Executive Officer

 

Rogelio Sandoval

Chief Financial Officer

 

Jose Luis Lopes

General Manager Brazil

 

Antonio Sanchez

General Manager México


Board of Directors

 

COPYRIGHT © 2006-2019 MOKSHA8 PHARMACEUTICALS, INC. ALL RIGHTS RESERVED. THIS INFORMATION—INCLUDING PRODUCT INFORMATION—IS INTENDED ONLY FOR RESIDENTS OF THE UNITED STATES. THE PRODUCTS DISCUSSED HEREIN MAY HAVE DIFFERENT LABELING IN DIFFERENT COUNTRIES.

 

PRIVACY POLICY | LEGAL DISCLAIMER | LINKEDIN | ENGLISH | PORTUGUESE

Management Team

Joel joined moksha8 in December 2014 as CEO. He has over 39 years of experience in the pharmaceutical industry, most of it has been spent in Latin America; working for leading pharmaceutical companies such as Sanofi and UCB. His most recent role, Joel was Interlatina regional manager for Sanofi, Latin America regional manager for UCB and CEO of Meizler UCB Brazil.

 

Joel brings extensive experience in leading highly successful teams, merging, acquiring, launching and marketing pharmaceutical products in Latin America, particularly in the CNS, Diabetes, Oncology and Respiratory therapeutic areas.

Joel Barlan

Chief Executive Officer

Rogelio Sandoval has served as our Chief Financial Officer since August 2015. He has over 18 years of broad-based domestic and international experience at pharmaceutical companies with significant operation scale, especially in Latin America.

Mr. Sandoval joins moksha8 from UCB the global biopharmaceutical focused on neurological and immunological diseases. Under his nine-year tenure he held several finance and operations positions, being Director, Finance Business Partner Latam Operations the last.

Before UCB, Mr. Sandoval held various progressive finance positions at Teva, IVAX Pharmaceuticals and Revlon, where he started his professional career. He received his BA in Accounting from UNITEC University.

Rogelio Sandoval

Chief Financial Officer

José Luís joined moksha8 Brazil in July 2015 as General Manager.

Before joining the company he held several senior management positions in leading companies of the health industry such as Ciba, Novartis, Sandoz, Mallinckrodt and UCB.

José Luís started his professional career in pharmaceutical industry back in 1986. He has an extensive experience leading successful teams in both commercial and technical areas and has a solid track record in launching and promoting pharmaceutical products in different segments such as Central Nervous System, Oncology, Cardiology, Medical Devices and Tender Business.

 

Before working for moksha8 he was the Commercial Operation Officer at UCB Brazil and at Covidien the Area Managing Director – Mallinckrodt Brazil and Latin America Southern Cone.

José Luís holds a Bachelor’s Degree in Pharmaceutical Sciences – USP – University of São Paulo, a Specialization in Industrial Management at POLI-USP and a Master’s Degree in Marketing – ESPM – Escola Superior de Propaganda e Marketing, São Paulo.

Jose Luis Lopes

General Manager Brazil

Antonio Sánchez joined moksha8 in May 2017 as our General Manager in Mexico. He has 32 years of experience in pharmaceutical companies, especially in México. He joins moksha8 from UCB the global pharmaceutical focused in neurological and immunological diseases, where he worked as Commercial Operations Director and Managing Director, the latter being his last position.

 

Prior to UCB Mr. Sánchez positions were in the sales and marketing areas in companies like Pharmacia & Upjohn, Organon and Searle.

He received a Bachelor of Business Administration degree from UNAM University.

Antonio Sanchez

General Manager Mexico

Management Team

Joel joined moksha8 in December 2014 as CEO. He has over 39 years of experience in the pharmaceutical industry, most of it has been spent in Latin America; working for leading pharmaceutical companies such as Sanofi and UCB. His most recent role, Joel was Interlatina regional manager for Sanofi, Latin America regional manager for UCB and CEO of Meizler UCB Brazil.

 

Joel brings extensive experience in leading highly successful teams, merging, acquiring, launching and marketing pharmaceutical products in Latin America, particularly in the CNS, Diabetes, Oncology and Respiratory therapeutic areas.

 

Joel Barlan

Chief Executive Officer

Rogelio Sandoval has served as our Chief Financial Officer since August 2015. He has over 19 years of broad-based domestic and international experience at pharmaceutical companies with significant operation scale, especially in Latin America.

 

Mr. Sandoval joins moksha8 from UCB the global biopharmaceutical focused on neurological and immunological diseases. Under his nine-year tenure he held several finance and operations positions, being Director, Finance Business Partner Latam Operations the last.

 

Before UCB, Mr. Sandoval held various progressive finance positions at Teva, IVAX Pharmaceuticals and Revlon, where he started his professional career. He received his BA in Accounting from UNITEC University.

 

Rogelio Sandoval

Chief Financial Officer

Jose Luis Lopes

General Manager Brazil

José Luís joined moksha8 Brazil in July 2015 as General Manager.

 

Before joining the company he held several senior management positions in leading companies of the health industry such as Ciba, Novartis, Sandoz, Mallinckrodt and UCB.

José Luís started his professional career in pharmaceutical industry back in 1986. He has an extensive experience leading successful teams in both commercial and technical areas and has a solid track record in launching and promoting pharmaceutical products in different segments such as Central Nervous System, Oncology, Cardiology, Medical Devices and Tender Business.

 

Before working for moksha8 he was the Commercial Operation Officer at UCB Brazil and at Covidien the Area Managing Director – Mallinckrodt Brazil and Latin America Southern Cone.

 

José Luís holds a Bachelor’s Degree in Pharmaceutical Sciences – USP – University of São Paulo, a Specialization in Industrial Management at POLI-USP and a Master’s Degree in Marketing – ESPM – Escola Superior de Propaganda e Marketing, São Paulo.

Antonio Sánchez joined moksha8 in May 2017 as our General Manager in Mexico. He has 32 years of experience in pharmaceutical companies, especially in México. He joins moksha8 from UCB the global pharmaceutical focused in neurological and immunological diseases, where he worked as Commercial Operations Director and Managing Director, the latter being his last position.

 

Prior to UCB Mr. Sánchez positions were in the sales and marketing areas in companies like Pharmacia & Upjohn, Organon and Searle.

He received a Bachelor of Business Administration degree from UNAM University.

Antonio Sanchez

General Manager Mexico

Joel Barlan

Chief Executive Officer

Joel joined moksha8 in December 2014 as CEO. He has over 39 years of experience in the pharmaceutical industry, most of it has been spent in Latin America; working for leading pharmaceutical companies such as Sanofi and UCB. His most recent role, Joel was Interlatina regional manager for Sanofi, Latin America regional manager for UCB and CEO of Meizler UCB Brazil.

 

Joel brings extensive experience in leading highly successful teams, merging, acquiring, launching and marketing pharmaceutical products in Latin America, particularly in the CNS, Diabetes, Oncology and Respiratory therapeutic areas.

Rogelio Sandoval

Chief Financial Officer

Rogelio Sandoval has served as our Chief Financial Officer since August 2015. He has over 19 years of broad-based domestic and international experience at pharmaceutical companies with significant operation scale, especially in Latin America.

 

Mr. Sandoval joins moksha8 from UCB the global biopharmaceutical focused on neurological and immunological diseases. Under his nine-year tenure he held several finance and operations positions, being Director, Finance Business Partner Latam Operations the last.

 

Before UCB, Mr. Sandoval held various progressive finance positions at Teva, IVAX Pharmaceuticals and Revlon, where he started his professional career. He received his BA in Accounting from UNITEC University.

 

Jose Luis Lopes

General Manager Brazil

José Luís joined moksha8 Brazil in July 2015 as General Manager.

 

Before joining the company he held several senior management positions in leading companies of the health industry such as Ciba, Novartis, Sandoz, Mallinckrodt and UCB.

José Luís started his professional career in pharmaceutical industry back in 1986. He has an extensive experience leading successful teams in both commercial and technical areas and has a solid track record in launching and promoting pharmaceutical products in different segments such as Central Nervous System, Oncology, Cardiology, Medical Devices and Tender Business.

 

Before working for moksha8 he was the Commercial Operation Officer at UCB Brazil and at Covidien the Area Managing Director – Mallinckrodt Brazil and Latin America Southern Cone.

 

José Luís holds a Bachelor’s Degree in Pharmaceutical Sciences – USP – University of São Paulo, a Specialization in Industrial Management at POLI-USP and a Master’s Degree in Marketing – ESPM – Escola Superior de Propaganda e Marketing, São Paulo.

Antonio Sanchez

General Manager Mexico

Antonio Sánchez joined moksha8 in May 2017 as our General Manager in Mexico. He has 33 years of experience in pharmaceutical companies, especially in México. He joins moksha8 from UCB the global pharmaceutical focused in neurological and immunological diseases, where he worked as Commercial Operations Director and Managing Director, the latter being his last position.

 

Prior to UCB Mr. Sánchez positions were in the sales and marketing areas in companies like Pharmacia & Upjohn, Organon and Searle.

He received a Bachelor of Business Administration degree from UNAM University.